TPMT and inflammatory bowel disease: Patients with leukemia or inflammatory bowel disease (IBD) who carry a TPMT mutation, especially those with biallelic mutations, can experience myelosuppression when undergoing treatment with thiopurine medications such as azathioprine and mercaptopurine.